BRPI0107952B8 - processo para produzir bisfosfonatos geminais - Google Patents

processo para produzir bisfosfonatos geminais

Info

Publication number
BRPI0107952B8
BRPI0107952B8 BRPI0107952A BR0107952A BRPI0107952B8 BR PI0107952 B8 BRPI0107952 B8 BR PI0107952B8 BR PI0107952 A BRPI0107952 A BR PI0107952A BR 0107952 A BR0107952 A BR 0107952A BR PI0107952 B8 BRPI0107952 B8 BR PI0107952B8
Authority
BR
Brazil
Prior art keywords
substituted
unsubstituted
producing
unsaturated
saturated
Prior art date
Application number
BRPI0107952A
Other languages
English (en)
Other versions
BRPI0107952B1 (pt
BR0107952A (pt
Inventor
Michael Billings Dennis
Dana Cazer Fredrick
Eugene Perry Gregory
Douglas Cramer William
Original Assignee
Procter & Gamble
Warner Chilcott Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble, Warner Chilcott Co Llc filed Critical Procter & Gamble
Publication of BR0107952A publication Critical patent/BR0107952A/pt
Publication of BRPI0107952B1 publication Critical patent/BRPI0107952B1/pt
Publication of BRPI0107952B8 publication Critical patent/BRPI0107952B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/386—Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"processo para produzir bisfosfonatos geminais". a presente invenção diz respeito a um novo processo para produzir bisfosfonatos geminais. o processo fornece bisfosforilação usando trialeto de fósforo, ácido fosforoso como um reagente/solvente e uma base como um receptor/solvente de ácido. a presente invenção é direcionada a um processo para produzir bisfosfonatos geminais da fórmula (i), em que q é oxigênio, -nr4-, enxofre, selênio ou uma ligação simples; m+n é um número inteiro de 0 a cerca de 5, z é um anel selecionado do grupo que consiste em piridina, piridazina, pirimidina e pirazina; r~ 1~ é hidrogênio, amino substituído ou não-substituído, amido, hidróxi, alcóxi, halogênio, carboxilato, alquila substituída ou não-substituída (saturada ou insaturada) tendo de 1 a cerca de 6 átomos de carbono, arila substituída ou não-substituída, ou benzila substituída ou não-substituída; cada r~ 2~ é independentemente, hidrogênio, ou alquila substituída ou não-substituída (saturada ou insaturada) tendo de 1 a cerca de 4 átomos de carbono; r~ 3~ é um ou mais substituintes selecionados do grupo que consiste em hidrogênio, alquila substituída ou não-substituída (saturada ou insaturada) tendo de 1 a cerca de 6 átomos de carbono, arila substituída e não-substituída, benzila substituída e não-substituída, hidróxi, halogênio, carbonila, alcóxi, nitro, amido, amino, amino substituído, carboxilato e combinações destes; r~ 4~ é hidrogênio, alquila substituída (saturada ou insaturada) tendo de 1 a cerca de 4 átomos de carbono, ou acila.
BRPI0107952A 2000-02-01 2001-02-01 processo para produzir bisfosfonatos geminais BRPI0107952B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17950600P 2000-02-01 2000-02-01
PCT/US2001/003309 WO2001057052A1 (en) 2000-02-01 2001-02-01 Process for making geminal bisphosphonates

Publications (3)

Publication Number Publication Date
BR0107952A BR0107952A (pt) 2003-02-25
BRPI0107952B1 BRPI0107952B1 (pt) 2015-09-01
BRPI0107952B8 true BRPI0107952B8 (pt) 2021-05-25

Family

ID=22656872

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0107952A BRPI0107952B8 (pt) 2000-02-01 2001-02-01 processo para produzir bisfosfonatos geminais

Country Status (27)

Country Link
US (1) US6562974B2 (pt)
EP (1) EP1252169B1 (pt)
JP (1) JP4534185B2 (pt)
KR (1) KR100681740B1 (pt)
CN (1) CN1223598C (pt)
AT (1) ATE269343T1 (pt)
AU (1) AU784385B2 (pt)
BR (1) BRPI0107952B8 (pt)
CA (1) CA2399974C (pt)
CO (1) CO5430222A1 (pt)
CZ (1) CZ304038B6 (pt)
DE (1) DE60103851T2 (pt)
DK (1) DK1252169T3 (pt)
ES (1) ES2221887T3 (pt)
HK (1) HK1051045A1 (pt)
HU (1) HU228980B1 (pt)
IL (2) IL150512A0 (pt)
MX (1) MXPA02007418A (pt)
NO (1) NO330273B1 (pt)
NZ (1) NZ519967A (pt)
PE (1) PE20011065A1 (pt)
PL (1) PL207617B1 (pt)
PT (1) PT1252169E (pt)
RU (1) RU2002123362A (pt)
SK (1) SK10992002A3 (pt)
TR (1) TR200402317T4 (pt)
WO (1) WO2001057052A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
GB0115824D0 (en) * 2001-06-28 2001-08-22 Rhodia Cons Spec Ltd Improved solvent systems
EA006053B1 (ru) * 2001-12-24 2005-08-25 Тева Фармасьютикал Индастриес Лтд. Твёрдая лекарственная форма, способ её изготовления и устройство
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
ITMI20020908A1 (it) * 2002-04-29 2003-10-29 Chemi Spa Processo di preparazione di sodio alendronato
ATE461205T1 (de) * 2002-05-17 2010-04-15 Teva Pharma Verwendung von bestimmten lösungsmitteln zur herstellung von bisphosphonsäuren
ES2337063T3 (es) * 2003-08-21 2010-04-20 Sun Pharmaceuticals Industries Ltd. Proceso para la preparacion de acido bisfosfonico.
US20050260272A1 (en) * 2004-05-05 2005-11-24 Alkermes Controlled Therapeutics, Inc. Method of forming microparticles that include a bisphosphonate and a polymer
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
WO2006039721A2 (en) * 2004-10-08 2006-04-13 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
US7214818B2 (en) 2004-10-29 2007-05-08 Hoffmann-La Roche Inc. Method for synthesizing bisphosphonate
PL199215B1 (pl) * 2004-12-28 2008-08-29 Politechnika Gdanska Sposób wytwarzania kwasu [1-hydroksy-2-(3-pirydylo)etylidenobisfosfonowego] oraz jego soli monosodowej dwu i pół wodnej
WO2006129056A2 (en) * 2005-05-28 2006-12-07 Pliva Hrvatska D.O.O Process and novel salt
WO2006134603A1 (en) 2005-06-13 2006-12-21 Jubilant Organosys Limited Process for producing bisphosphonic acids and forms thereof
EP1775302A1 (en) 2005-10-11 2007-04-18 Sandoz A/S Method for preparing crystalline sodium risedronate
KR100860666B1 (ko) 2006-01-06 2008-09-26 삼성전자주식회사 통신 시스템에서 신호 수신 장치 및 방법
EP2001486A4 (en) * 2006-03-17 2010-12-29 Univ Illinois BIPHOSPHONATE COMPOUNDS AND CORRESPONDING METHODS
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
EP2016084A2 (en) 2006-05-11 2009-01-21 Ind-Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
PT103600B (pt) * 2006-11-06 2009-01-30 Hovione Farmaciencia Sa Processo para a preparação de ácidos biosfónicos e seus sais farmaceuticamente aceitáveis
EP2144919B1 (en) 2007-04-11 2015-12-02 F. Hoffmann-La Roche AG Multi step synthesis of ibandronate
WO2008152518A2 (en) * 2007-05-16 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of risedronic acid or risedronate sodium
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
KR100877667B1 (ko) * 2007-06-28 2009-01-08 보령제약 주식회사 리세드로네이트의 제조 방법
BRPI0908448A2 (pt) * 2008-03-17 2019-09-24 Cabot Corp pigmentos modificados tendo liberação de fosfato reduzida, e dispersões e composições de tinta para jato de tinta com os mesmos
JP5258370B2 (ja) * 2008-05-08 2013-08-07 ダイト株式会社 リセドロン酸の工業的製造方法
CA2775004A1 (en) 2009-10-02 2011-04-07 Straitmark Holding Ag Method for the manufacture of aminohydroxy diphosphonic acids

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2534391C2 (de) 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2658961C3 (de) 1976-12-24 1981-09-24 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von 1-Hydroxy-3-amino-propan-1,1-diphosphonsäuren
US4447256A (en) 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
DE2745083C2 (de) 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
US4330537A (en) 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
JPS5598193A (en) 1979-01-22 1980-07-25 Nissan Chem Ind Ltd Methylenediphosphonic acid derivative and herbicide comprising it as active constituent
DE2943498C2 (de) 1979-10-27 1983-01-27 Henkel KGaA, 4000 Düsseldorf Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsäure
DE3016289A1 (de) 1980-04-28 1981-10-29 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
US4304734A (en) 1980-10-16 1981-12-08 Vysoka Skola Chemicko-Technologicka 6-Amino-1-hydroxyhexylidene diphosphonic acid, salts and a process for production thereof
DE3151038A1 (de) 1981-12-23 1983-07-28 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
IT1201087B (it) 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1196315B (it) 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
IL77243A (en) 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
IT1187750B (it) 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
DE3540150A1 (de) 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
GB8531071D0 (en) 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
DE3773716D1 (de) 1986-03-24 1991-11-21 Nippon Kayaku Kk Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3626058A1 (de) 1986-08-01 1988-02-11 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ES2038692T4 (es) 1986-11-21 2012-02-10 Novartis Ag Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos.
DE3700772A1 (de) 1987-01-13 1988-07-21 Inst Khim Kinetiki I Gorenija Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen
US5091525A (en) 1987-10-07 1992-02-25 Eli Lilly And Company Monohydrate and DMF solvates of a new carbacephem antibiotic
US5035898A (en) 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
US5110807A (en) 1988-12-01 1992-05-05 Ciba-Geigy Corporation Araliphatylaminoalkanediphosphonic acids
DE3822650A1 (de) 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3917153A1 (de) 1989-05-26 1990-11-29 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
TW208013B (pt) 1990-03-01 1993-06-21 Daiichi Co Ltd
AU8495091A (en) 1990-08-21 1992-03-17 Upjohn Company, The Bisphosphonic acid derivatives as anti-arthritic agents
US5039819A (en) 1990-09-18 1991-08-13 Merck & Co., Inc. Diphosphonate intermediate for preparing an antihypercalcemic agent
IT1246992B (it) * 1991-01-08 1994-12-12 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici e loro sali
DK58291D0 (da) 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
SE501389C2 (sv) 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
US5317015A (en) 1992-05-01 1994-05-31 Rhone-Poulenc Rorer Pharmaceuticals Inc. Azacyclic bisphosphonates as anticholesterolemic agents
WO1994000462A1 (fr) 1992-06-23 1994-01-06 Yamanouchi Pharmaceutical Co., Ltd. Nouveau cristal de monohydrate de derive de bis(acide phosphonique) heterocyclique
FR2694558B1 (fr) 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
US5312925A (en) 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
WO1994025479A1 (en) 1993-04-28 1994-11-10 Pfizer Inc. Spirostanyl glycosidal crystalline monohydrate
US5510517A (en) 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5580977A (en) 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
TW393488B (en) 1995-04-20 2000-06-11 Merck & Co Inc Process for making 1-hydrox-ybisphosphonates
KR100192215B1 (ko) 1996-09-03 1999-06-15 강재헌 3-아미노-1-히드록시프로판-1,1-디포스폰산의 제조방법
CA2197267C (en) 1997-02-11 2000-02-08 Yong Tao Process for the production of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof

Also Published As

Publication number Publication date
MXPA02007418A (es) 2002-12-09
RU2002123362A (ru) 2004-01-10
DK1252169T3 (da) 2004-10-25
EP1252169B1 (en) 2004-06-16
CZ304038B6 (cs) 2013-09-04
KR20020063622A (ko) 2002-08-03
EP1252169A1 (en) 2002-10-30
PL207617B1 (pl) 2011-01-31
JP4534185B2 (ja) 2010-09-01
KR100681740B1 (ko) 2007-02-15
TR200402317T4 (tr) 2004-12-21
ATE269343T1 (de) 2004-07-15
US20010041690A1 (en) 2001-11-15
NO20023646L (no) 2002-09-30
PT1252169E (pt) 2004-11-30
WO2001057052A1 (en) 2001-08-09
AU3661301A (en) 2001-08-14
IL150512A0 (en) 2003-02-12
NO20023646D0 (no) 2002-07-31
CN1223598C (zh) 2005-10-19
ES2221887T3 (es) 2005-01-16
AU784385B2 (en) 2006-03-23
HUP0300890A3 (en) 2009-01-28
JP2003522181A (ja) 2003-07-22
CN1396925A (zh) 2003-02-12
CA2399974C (en) 2005-08-16
DE60103851T2 (de) 2005-06-23
US6562974B2 (en) 2003-05-13
SK10992002A3 (sk) 2003-02-04
NZ519967A (en) 2004-05-28
NO330273B1 (no) 2011-03-14
HU228980B1 (en) 2013-07-29
PL357116A1 (en) 2004-07-12
CA2399974A1 (en) 2001-08-09
HK1051045A1 (zh) 2003-07-18
IL150512A (en) 2006-10-31
BRPI0107952B1 (pt) 2015-09-01
PE20011065A1 (es) 2001-11-21
HUP0300890A2 (hu) 2003-08-28
CO5430222A1 (es) 2004-06-01
DE60103851D1 (de) 2004-07-22
BR0107952A (pt) 2003-02-25

Similar Documents

Publication Publication Date Title
BR0107952A (pt) Processo para produzir bisfosfonatos geminais
MA32249B1 (fr) Dérivés polysubstitues de 2-heteroaryl-6-phenyl-imidazo[1,2- a]pyridines, leur préparation et leur application en thérapeutique
BR0009187A (pt) Processo para a carbonilação de dienosconjugados, processo para prepararcaprolactama, náilon 6 ou náilon 6,6, sistemacatalisador, e, uso deste
CO4990933A1 (es) Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica
DE69814991D1 (de) Copolymere aus alpha-olefin und cycloolefin und verfahren zu ihrer herstellung
BR9911250A (pt) Processo para preparação de compostos
AR038664A1 (es) Aroil pirrol heteroaril metanonas y metanoles utiles como agentes para el tratamiento o modulación de desorden del sistema nervioso central
DE50005204D1 (de) Verfahren zur herstellung von aldehyden
DE60103923D1 (de) Verfahren zur herstellung von razemischer thioctsäure
ATE256108T1 (de) Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen
BR0112413A (pt) Derivados de variolina como agentes anticâncer
BRPI0513299A (pt) processo para preparação de ésteres de ácido 4, 4-difluoro-3-oxobutanóico
BR9813923A (pt) N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos
ES2179634T3 (es) Preparacion de ligandos de fosfina.
DE69915623D1 (de) 2-aminothiazol-kondensierte 2-aminoindane und 2-aminotetraline, sowie deren verwendung
DE50113691D1 (de) Verfahren zur Herstellung von Ethylen-1,2-diphosphonsäuren
MY134246A (en) Diphosphine
BRPI0410613A (pt) preparação de quinoxalinas substituìdas a partir da dianlina com 2,3-diidróxi-1,4-dioxano
BR9814161A (pt) Método de sìntese de pirrolamidas
EP1708026A4 (en) PHOTOSENSITIVE POLYMER COMPOSITION, METHOD FOR GENERATING A PATTERN, AND ELECTRONIC COMPONENT
DE68928127D1 (de) 2'-Methylidenpyrimidinnukleosidverbindungen, ihre Verwendung und Verfahren zu ihrer Herstellung
HUP0101356A2 (hu) Eljárás 1,3-diszubsztituált-4-oxo-ciklikus karbamidok előállítására
DE602005011432D1 (de) Herstellung von aminophosphinen
DE60220275D1 (de) Verwendung von sulfamidsäuren als racematspaltungsmittel
BR0016170A (pt) Processo para preparação de tienopirimidinas

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07F 9/38, A61K 31/663, A61P 19/10

Ipc: C07F 9/38 (2006.01), A61K 31/663 (2006.01), A61P 1

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: WARNER CHILCOTT COMPANY, LLC (PR)

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/09/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25E Requested change of name of applicant rejected
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/02/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 01/02/2021

B25E Requested change of name of applicant rejected

Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870220023197 DE 17/03/2022, EM VIRTUDE DA EXTINCAO (21.1) ART. 78 INCISO I DA LPI PUBLICADA NA RPI 2630 DE 01/06/2021.

B25B Requested transfer of rights rejected

Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA CONTIDO NA PETICAO 870220023210 DE 17/03/2022, EM VIRTUDE DA EXTINCAO (21.1) ART. 78 INCISO I DA LPI, PUBLICADA NA RPI2630 DE 01/06/2021.